Published in Gynecol Oncol on January 22, 2014
Improving Self-Monitoring in Weight Loss With Technology | NCT00277771
TENDINOPATHY AND OBESITY. Arq Bras Cir Dig (2016) 0.79
A possible role for ghrelin, leptin, brain-derived neurotrophic factor and docosahexaenoic acid in reducing the quality of life of coeliac disease patients following a gluten-free diet. Eur J Nutr (2015) 0.75
Molecular mechanisms of cancer development in obesity. Nat Rev Cancer (2011) 3.65
Ten-year trends in health-related quality of life after surgical and conventional treatment for severe obesity: the SOS intervention study. Int J Obes (Lond) (2007) 2.95
SMART trial: A randomized clinical trial of self-monitoring in behavioral weight management-design and baseline findings. Contemp Clin Trials (2009) 2.01
Obesity and colon cancer: does leptin provide a link? Int J Cancer (2004) 1.89
Body mass index, hormone replacement therapy, and endometrial cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev (2010) 1.75
The leptin hypothesis of depression: a potential link between mood disorders and obesity? Curr Opin Pharmacol (2007) 1.68
Reproducibility of serum cytokines and growth factors. Cytokine (2008) 1.61
The role of adipose tissue and adipokines in obesity-related inflammatory diseases. Mediators Inflamm (2010) 1.59
Comparing the SF-12 and SF-36 health status questionnaires in patients with and without obesity. Health Qual Life Outcomes (2008) 1.45
Leptin promotes the proliferative response and invasiveness in human endometrial cancer cells by activating multiple signal-transduction pathways. Endocr Relat Cancer (2006) 1.41
PREFER study: a randomized clinical trial testing treatment preference and two dietary options in behavioral weight management--rationale, design and baseline characteristics. Contemp Clin Trials (2005) 1.38
Impact of weight loss on health-related quality of life. Qual Life Res (1999) 1.38
Leptin and body mass index in relation to endometrial cancer risk. Ann Nutr Metab (2002) 1.20
Improved psychological well-being, quality of life, and health practices in moderately overweight women participating in a 12-week structured weight loss program. Obes Res (1998) 1.20
Reliability of tumor markers, chemokines, and metastasis-related molecules in serum. Eur Cytokine Netw (2009) 1.16
Clinical relevance of adipokines. Diabetes Metab J (2012) 1.10
Obesity hormone leptin: a new target in breast cancer? Breast Cancer Res (2007) 1.10
Correlation of body mass index and leptin with tumor size and stage of disease in hormone-dependent postmenopausal breast cancer: preliminary results and therapeutic implications. J Mol Med (Berl) (2010) 1.08
Serum leptin-adiponectin ratio and endometrial cancer risk in postmenopausal female subjects. Gynecol Oncol (2010) 1.08
Prospective identification, isolation, and profiling of a telomerase-expressing subpopulation of human neural stem cells, using sox2 enhancer-directed fluorescence-activated cell sorting. J Neurosci (2010) 1.05
A randomized clinical trial testing treatment preference and two dietary options in behavioral weight management: preliminary results of the impact of diet at 6 months--PREFER study. Obesity (Silver Spring) (2006) 1.03
Expression of leptin, leptin receptor, and hypoxia-inducible factor 1 alpha in human endometrial cancer. Ann N Y Acad Sci (2007) 1.01
The Role of Adipokines in Understanding the Associations between Obesity and Depression. J Obes (2010) 0.98
Serum levels of adipokines resistin and leptin in patients with colon cancer. J Med Life (2011) 0.96
Reproducibility of serum pituitary hormones in women. Cancer Epidemiol Biomarkers Prev (2008) 0.95
Health-related quality of life in adult patients with morbid obesity coming for bariatric surgery. Obes Surg (2008) 0.92
Socioeconomic variation in the impact of obesity on health-related quality of life. Soc Sci Med (2010) 0.91
Relationship of resistin levels with endometrial cancer risk. Neoplasma (2011) 0.89
Health-related quality of life in adolescents with comorbidities related to obesity. J Adolesc Health (2011) 0.88
Leptin activates STAT3 and ERK1/2 pathways and induces endometrial cancer cell proliferation. J Huazhong Univ Sci Technolog Med Sci (2011) 0.87
Validity of the SF-36 in patients with morbid obesity. Obes Facts (2011) 0.87
Health-related quality of life in obesity: the role of eating behaviour. Diabetes Nutr Metab (2000) 0.85
Longitudinal evaluation of cancer-associated biomarkers before and after weight loss in RENEW study participants: implications for cancer risk reduction. Gynecol Oncol (2011) 0.83
Prospective study of health-related quality of life after Roux-en-Y bypass surgery for morbid obesity. Br J Surg (2010) 0.83
Serum adipokine levels in adults with a history of childhood maltreatment. Prog Neuropsychopharmacol Biol Psychiatry (2012) 0.82
A lower serum level of middle-molecular-weight adiponectin is a risk factor for endometrial cancer. Int J Clin Oncol (2013) 0.80
Adiponectin and negative mood in healthy premenopausal and postmenopausal women. Horm Behav (2010) 0.80
Obesity as a risk factor for endometrial cancer. Clin Exp Obstet Gynecol (1987) 0.80
Adiponectin to leptin index as a marker of endometrial cancer in postmenopausal women with abnormal vaginal bleeding: an observational study. Neuro Endocrinol Lett (2012) 0.78
Health-related quality of life among participants in the SMART weight loss trial. Appl Nurs Res (2011) 0.77